NDC 65162-698-39 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65162-698
- Requested NDC
- 65162-698-39
- Package NDCs from labels
- 65162-698-90, 65162-698-39, 65162-698-54
- Manufacturer
- Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC
- Effective date
- 2025-05-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | 2025-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Gabapentin - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2023-04-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65162-698-39 | Gabapentin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 28 | |
| 65162-698-54 | Gabapentin | 50 in 1 CARTON | SOLUTION | 50 | 28 | |
| 65162-698-90 | Gabapentin | 473 mL in 1 BOTTLE | SOLUTION | 473 | 28 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65162-698-90 | ML - Milliliter | 65162-698 | 781d1576-35f2-4340-9bb7-8435d1507cd5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | INACTIVE INGREDIENT | K679OBS311 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4a975ebe-ae0a-446a-8a3d-2ca325e28f93 | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 167d8b87-506c-4293-9579-563feaa71583 | 2026-09-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Clinical Solutions Wholesale, LLC | b7f9a106-52c6-49e4-acf5-8fb07761ba4f | 2026-09-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | K679OBS311 |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | d35cd5ac-5ed6-2405-e053-2995a90a6946 | 2026-09-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | PHOENIX RX LLC | 5a85ea98-4211-54eb-e063-6294a90aff33 | 2026-09-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 3dac0d5f-6e65-4c58-9d2a-4f6910b2d4ef | 2026-09-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | 1373587e-807a-462a-bff6-8a7113ce9f0a | 2026-09-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 78445dbf-c7cd-419f-a7be-72821e496628 | 2026-08-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| REFRESH LIQUIGEL | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 4b8b2f6a-4b89-446c-9e5b-9b83c453a01d | 2026-08-28 | Warnings | K679OBS311 |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4615aaa7-73d4-4473-8f26-e7a982f8a166 | 2026-08-27 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 1af098ad-28b5-463f-8efa-24d70a77d64c | 2026-08-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 9a2658d5-9b0e-4921-b4c5-4c89f1630d69 | 2026-08-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 43cbff48-8219-41ba-b67d-3ae4544b78bb | 2026-08-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 4c22c3e6-2471-4b89-945b-f846c4d7884e | 2026-08-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | d06380d0-c894-427e-b13e-5a8f9eb86a34 | 2026-08-21 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7652adc6-1aad-4422-b85c-0c6b11c23b73 | 2026-08-21 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | f0e7a6c9-ae6c-4259-81ab-a37db54e3c80 | 2026-08-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 596eb696-7696-202e-e063-6394a90a2844 | 2026-08-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | eb2f6784-e7be-41b6-871b-2c3c961664ab | 2026-08-19 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.